35.76
Collegium Pharmaceutical Inc (COLL) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
| 期間終了日 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues |
5.76%
188.00
|
177.76 | 159.30 | 145.28 | 144.92 |
| Cost Of Revenue |
1.02%
79.62
|
80.43 | 62.51 | 54.47 | 53.47 |
| Gross Profit |
11.36%
108.38
|
97.32 | 96.79 | 90.81 | 91.46 |
| Operating Expenses |
3.12%
73.28
|
75.64 | 61.95 | 43.34 | 41.98 |
| Benefits Costs and Expenses |
2.10%
170.97
|
174.63 | 143.72 | 116.18 | 108.30 |
| Costs And Expenses |
2.10%
170.97
|
174.63 | 143.72 | 116.18 | 108.30 |
| Operating Income/Loss |
61.87%
35.10
|
21.69 | 34.84 | 47.47 | 49.47 |
| Income/Loss From Continuing Operations Before Tax |
445.32%
17.02
|
3.122 | 15.58 | 29.10 | 36.62 |
| Income Tax Expense/Benefit, Deferred |
440.63%
-2.914
|
-0.539 | -8.733 | -3.513 | -4.412 |
| Income Tax Expense/Benefit |
615.18%
5.042
|
0.705 | 6.245 | 9.491 | 8.909 |
| Income/Loss From Continuing Operations After Tax |
395.78%
11.98
|
2.417 | 9.335 | 19.61 | 27.71 |
|
|
395.78%
11.98
|
2.417 | 9.335 | 19.61 | 27.71 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.05%
31.81
|
31.79 | 32.26 | 32.43 | 32.33 |
| Diluted Average Shares |
18.99%
39.08
|
32.84 | 40.16 | 40.38 | 41.44 |
| Basic Earnings Per Share |
375.00%
0.38
|
0.08 | 0.29 | 0.60 | 0.86 |
| Diluted Earnings Per Share |
385.71%
0.34
|
0.07 | 0.27 | 0.52 | 0.71 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):